Skip to content

Rapid tranquillisation for agitated patients in emergency psychiatric rooms.

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone for reduction in agitation.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000033044
Enrollment
150
Registered
2010-01-12
Start date
2010-01-18
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Agitated or violent behavior, mostly as a result of serious mental illness and substance misuse constitutes around 10% of the reasons for use of emergency services. The drugs used in such situations should calm patients safely and swiftly. Guidelines, however, are usually statements of consensus and differ on which drugs to use. Some of the new generation antipsychotics are really not only for oral use but also for parenteral use such as olanzapine and ziprasidone. These medications means an advance in rapid manage of acute behavior alterations. By the way, knowledge about antipsychotics profile in agitation and aggressive behavior is limited and few studies compare several drugs in rapid tranquilization. The objective of this study is to compare five options of parenteral (intramuscular) antipsychotics, including olanzapine, ziprasidone, haloperidol, haloperidol plus promethazine and haloperidol plus midazolam as first medication in agitation.

Interventions

One hundred fifty subjects in agitation secundary to psychotic or bipolar disorder will be selected randomly for one of five rapid tranquilization options by intramuscular administration at baseline: olanzapine 10mg, ziprasidone 20mg, haloperidol 5mg plus midazolam 15mg, haloperidol 5mg plus promethazine 50mg and haloperidol 5mg alone. They will be revaluated after one hour, two hours, four hours, six hours and twelve hours after first medication by Overt Agitation Severity Scale, Overt Agressio

One hundred fifty subjects in agitation secundary to psychotic or bipolar disorder will be selected randomly for one of five rapid tranquilization options by intramuscular administration at baseline: olanzapine 10mg, ziprasidone 20mg, haloperidol 5mg plus midazolam 15mg, haloperidol 5mg plus promethazine 50mg and haloperidol 5mg alone. They will be revaluated after one hour, two hours, four hours, six hours and twelve hours after first medication by Overt Agitation Severity Scale, Overt Agression Scale and Ramsay Sedation Scale after 1 hours, 2 hours, 4 hours, 6 hours and 12 hours after first administration. When necessary aditional medication haloperidol 5mg plus promethazine 50mg will be used for all groups. This protocol will used for 12 hours.

Sponsors

Federal University of Tocantins
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Any subject in agitation, between 18 and 50 years of age, by bipolar or psychotic disorder by Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR criteria), Overt Agitation Severity Scale Total Score (OASS) equal or under 20 and Overt Aggressive Scale (OAS) with equal or less 4 positive itens.

Exclusion criteria

Disorders due to drug abuse, organic disorder, anxiety or personality disorder by Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR criteria), no concordance to research, incapable to proceed all steps and not stable clinical disease.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026